ConductScience.org, home

Paper7684237

Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor.

Hollmann M and 6 others. Neuron, 1993. Cited by 553 papers, by iCite.

Cite this record

ConductScience Library. Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor. Papers, record 7684237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7684237

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor.
PubMed
Journal
Neuron
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
553
iCite
Relative citation ratio, by iCite
13.9
iCite
Revised in PubMed
2019-08-21
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hollmann MM
2Boulter JJ
3Maron CC
4Beasley LL
5Sullivan JJ
6Pecht GG
7Heinemann SS

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
RNA SplicingMajor topic
Receptors, N-Methyl-D-AspartateMajor topic
ZincMajor topic
Animals
Base Sequence
Cations
DNA
Drug Synergism
Electric Conductivity
Exons
Gene Deletion
Gene Expression
Genetic Variation
Introns
Molecular Sequence Data
Oocytes
RNA
RNA, Complementary
Rats
Transfection
Xenopus

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
5 R01 NS12961NINDS NIH HHSUnited StatesR01NS012961PubMed and NIHNIH RePORTER
NS11549NINDS NIH HHSUnited StatesR01NS011549PubMed and NIHNIH RePORTER
NS28709NINDS NIH HHSUnited StatesR01NS028709PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by137

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 553 citations.

PMIDTitleJournalYearIn PapersSource
42251425N-Methyl-D-aspartate receptors: structure, signaling and roles in atherosclerosis.J Transl Med2026https://conductscience.org/library/papers/42251425PubMed
41743937Positive modulators of N-methyl-d-aspartate receptor: structure-activity relationship study on steroidal C-17 and C-20 oxime ethers.RSC Adv2026https://conductscience.org/library/papers/41743937PubMed
40745149The serum trace metal signature distinguishes patients with psychiatric disorders from healthy controls.Biometals2025https://conductscience.org/library/papers/40745149PubMed
38727903Selective Cell-Surface Expression of Triheteromeric NMDA Receptors.Methods Mol Biol2024https://conductscience.org/library/papers/38727903PubMed
38214768
Disease-associated nonsense and frame-shift variants resulting in the truncation of the GluN2A or GluN2B C-terminal domain decrease NMDAR surface expression and reduce potentiating effects of neurosteroids.
Cell Mol Life Sci2024https://conductscience.org/library/papers/38214768PubMed
38136657Role of NMDA Receptor in High-Pressure Neurological Syndrome and Hyperbaric Oxygen Toxicity.Biomolecules2023https://conductscience.org/library/papers/38136657PubMed
37880519NR1 Splicing Variant NR1a in Cerebellar Granule Neurons Constitutes a Better Motor Learning in the Mouse.Cerebellum2024https://conductscience.org/library/papers/37880519PubMed
37679470
DNA methylation and the opposing NMDAR dysfunction in schizophrenia and major depression disorders: a converging model for the therapeutic effects of psychedelic compounds in the treatment of psychiatric illness.
Mol Psychiatry2023https://conductscience.org/library/papers/37679470PubMed
37492081Theoretical design for covering Engeletin with functionalized nanostructure-lipid carriers as neuroprotective agents against Huntington's disease via the nasal-brain route.Front Pharmacol2023https://conductscience.org/library/papers/37492081PubMed
37239037Pharmacological Potential of 3-Benzazepines in NMDAR-Linked Pathophysiological Processes.Biomedicines2023https://conductscience.org/library/papers/37239037PubMed
36169098GluN2A-Selective NMDA Receptor Antagonists: Mimicking the U-Shaped Bioactive Conformation of TCN-201 by a [2.2]Paracyclophane System.ChemMedChem2022https://conductscience.org/library/papers/36169098PubMed
34753794Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.Pharmacol Rev2021https://conductscience.org/library/papers/34753794PubMed
34208315Amyloid Beta-Mediated Changes in Synaptic Function and Spine Number of Neocortical Neurons Depend on NMDA Receptors.Int J Mol Sci2021https://conductscience.org/library/papers/34208315PubMed
34100982Splicing and editing of ionotropic glutamate receptors: a comprehensive analysis based on human RNA-Seq data.Cell Mol Life Sci2021https://conductscience.org/library/papers/34100982PubMed
33131183Qualitative review on N-methyl-D-aspartate receptor expression in rat spinal cord during the postnatal development: Implications for central sensitization and pain.Dev Neurobiol2020https://conductscience.org/library/papers/33131183PubMed
32611707Site of Action of Brain Neurosteroid Pregnenolone Sulfate at the N-Methyl-D-Aspartate Receptor.J Neurosci2020https://conductscience.org/library/papers/32611707PubMed
32342094Cadmium activates AMPA and NMDA receptors with M3 helix cysteine substitutions.J Gen Physiol2020https://conductscience.org/library/papers/32342094PubMed
32070387Tripartite signalling by NMDA receptors.Mol Brain2020https://conductscience.org/library/papers/32070387PubMed
31987864PTC-174, a positive allosteric modulator of NMDA receptors containing GluN2C or GluN2D subunits.Neuropharmacology2020https://conductscience.org/library/papers/31987864PubMed
31786200NMDA receptors containing GluN2C and GluN2D subunits have opposing roles in modulating neuronal oscillations; potential mechanism for bidirectional feedback.Brain Res2020https://conductscience.org/library/papers/31786200PubMed

See all 137 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GRIN12902PubTator's text mininghttps://conductscience.org/library/genes/2902

Source NCBI Gene

Download CSV of genes

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
GENBANKL08228

Source GENBANK

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7684237

GET https://conductscience.org/api/papers/v1/7684237/cited_by?page=2